Loading decisions…
Loading decisions…
2,243 vetted Board decisions in 2018.
The Board has remanded the case for additional development, including obtaining VA and private treatment records, service treatment records, and a VA examination. The Veteran's claim will be reconsidered based on the new evidence.
The Board found that the Veteran's pseudofolliculitis barbae (PFB) did not meet the criteria for a compensable rating under VA disability evaluation criteria, as it affected less than 5 percent of his total body area and exposed areas without requiring intermittent systemic therapy such as with corticosteroids or other immunosuppressive drugs. Therefore, the claim was denied.
The Veteran's skin disability is presumed due to in-service exposure to an herbicide agent. However, the claim requires further examination and evidence to determine if it is related to service.
The Veteran's initial disability rating for diabetes mellitus was denied, but he is now rated at 30 percent for dermatitis. The decision also notes that the Veteran has other service-connected disabilities including peripheral neuropathy and erectile dysfunction.
The Veteran's bilateral foot disability and PFB have been granted service connection, with a noncompensable initial rating for both conditions. The Board has determined that the Veteran's calluses on his feet meet the criteria for a 10% rating under DC 5284, while his PFB does not warrant any compensable rating.
The Veteran's claims for service connection for obstructive sleep apnea, folliculitis of the scalp, and bilateral hearing loss have been granted. The claim for a rating in excess of 10 percent for lumbosacral strain prior to November 21, 2010, and in excess of 20 percent thereafter remains pending.
The Veteran's initial rating for eczema was increased to 10% prior to October 2, 2013. The right eye disability claim is denied as there is no evidence of a current disability or causation related to service. The ADHD claim is also denied due to lack of evidence showing the condition began during service and being otherwise unrelated to service.
The Board has remanded the case due to insufficient evidence regarding the use of systemic medications for the Veteran's service-connected skin disabilities prior to July 3, 2013.
The Veteran's appeal has been withdrawn by the appellant and his representative, thus all claims are dismissed.
The Veteran's lung cancer, skin rash (seborrheic dermatitis and rosacea), right knee degenerative joint disease, and left knee degenerative joint disease were all denied service connection as they are not related to his military service.,Special monthly compensation based on the need for aid and attendance was also denied due to lack of evidence showing that the Veteran or his spouse required regular assistance.
The Board denied the Veteran's claims for service connection for dysentery and residuals of dysentery, as well as an increased rating for neurodermatitis. The Veteran's current symptoms are not related to his military service or any presumptive exposure basis. His claim for earlier effective date for TDIU was also denied.
The Veteran's dermatitis is granted service connection as it had onset during active duty. The claims for memory loss and sleep disturbances are denied as they are found to be symptoms of his already service-connected other specified trauma and stressor related disorder.
The Veteran's hives are found to be aggravated by his service-connected PTSD, and thus granted service connection.,Prior to May 22, 2012, the initial rating for eczema was denied as it did not meet the criteria for a compensable rating.
The Veteran's chloracne results in the presence of five or more painful scars, qualifying for a 30 percent rating under Diagnostic Code 7804.
The Veteran's initial ratings for asthma with rhinitis and sleep apnea were restored, while the skin disorder claim was remanded.
The Veteran's claims for service connection for a skin disorder and prostate disorder were denied. The Board also found that the Veteran did not have current peripheral neuropathy or sinusitis, but granted service connection for diabetes mellitus due to herbicide exposure.
The Veteran's fungal dermatitis of the feet has been rated at 0 percent (noncompensable) since December 1, 2011. The Board found that the condition did not meet the criteria for a compensable rating based on the evidence showing topical therapy and no systemic corticosteroids or other immunosuppressive drugs were required.
The VA has determined that the Veteran's service-connected disability evaluations combine to an overall 60 percent rating under the Combined Ratings Table for the appellate period of September 2010 to February 2016.
The Board found no evidence of a causal relationship between the Veteran's skin disorder, hypertension, and diabetes mellitus, type II, and his military service. The conditions are determined to be related to periods of inactive duty.
The Board has dismissed the appeals for service connection of bilateral hearing loss, bilateral tinnitus, chronic fatigue syndrome, sleep apnea, dermatitis and skin disorder, headaches, and PTSD as they have already been granted by the RO.
← Back to Skin conditions (dermatitis, eczema, psoriasis) overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.